Modified CEA nucleic acid and expression vectors

Details for Australian Patent Application No. 2003223527 (hide)

Owner Sanofi Pasteur Limited

Inventors Gritz, Linda R; Parrington, Mark; Rovinski, Beni; Zhang, Linong; Greenhalgh, Trish

Agent Spruson & Ferguson

Pub. Number AU-B-2003223527

PCT Number PCT/US03/10916

PCT Pub. Number WO2003/085087

Priority 60/370,972 09.04.02 US

Filing date 9 April 2003

Wipo publication date 20 October 2003

Acceptance publication date 15 January 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61F 2/28 (2006.01) Filters - Bones

A61F 2/44 (2006.01) Filters - for the spine, e.g. vertebrae, spinal discs

A61F 2/46 (2006.01) Filters - Special tools for implanting artificial joints

A61K 39/275 (2006.01) Medicinal preparations containing antigens or antibodies - Poxviridae, e.g. avipoxvirus

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61B 17/28 (2006.01) Surgery - Surgical forceps

A61F 2/00 (2006.01) Filters

A61F 2/30 (2006.01) Filters - Joints

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/370,972 09.04.02 US

27 November 2003 Application Open to Public Inspection

  Published as AU-B-2003223527

15 January 2009 Alteration of Name

  The name of the applicant has been altered to Therion Biologics, Inc.; Sanofi Pasteur Limited

15 January 2009 Assignment before Grant

  Sanofi Pasteur Limited; Therion Biologics, Inc. The application has been assigned to Sanofi Pasteur Limited

15 January 2009 Application Accepted

  Published as AU-B-2003223527

14 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003223528-TREATMENT FOR TYPE 1 DIABETES BEFORE AND AFTER EXPRESSION OF PREDISPOSITION MARKERS.

2003223526-A GENE ABNORMALLY EXPRESSED IN AUTOIMMUNE DISEASES AND MALIGNANCIES